• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Experience is Key: Considerations of Gastrectomy During CRS/HIPEC for Extensive Pseudomyxoma Peritonei.

作者信息

Dineen Sean P

机构信息

Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.

出版信息

Ann Surg Oncol. 2025 Jan;32(1):17-18. doi: 10.1245/s10434-024-16188-7. Epub 2024 Sep 17.

DOI:10.1245/s10434-024-16188-7
PMID:39289246
Abstract
摘要

相似文献

1
Experience is Key: Considerations of Gastrectomy During CRS/HIPEC for Extensive Pseudomyxoma Peritonei.经验是关键：广泛性腹膜假黏液瘤的CRS/HIPEC手术中胃切除术的考量
Ann Surg Oncol. 2025 Jan;32(1):17-18. doi: 10.1245/s10434-024-16188-7. Epub 2024 Sep 17.
2
Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?在减瘤手术中，对于某些腹膜假黏液瘤肿瘤负荷严重的患者，是否应考虑行全胃切除术和全结肠切除术？
Eur J Surg Oncol. 2016 Jul;42(7):1018-23. doi: 10.1016/j.ejso.2016.04.059. Epub 2016 May 19.
3
An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.接受细胞减灭术联合腹腔热灌注化疗（CRS-HIPEC）治疗的结直肠腹膜转移或假性黏液瘤患者的观察性队列研究：荷兰 CRS-HIPEC 质量登记处的制定和初步结果。
Eur J Surg Oncol. 2024 Dec;50(12):108568. doi: 10.1016/j.ejso.2024.108568. Epub 2024 Aug 14.
4
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.细胞减灭术和腹腔热灌注化疗治疗腹膜癌转移：丹麦经验。
Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.
5
Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.腹腔镜细胞减灭术和 HIPEC 治疗低度假黏液瘤腹膜和多房性间皮瘤的疗效观察。
Surg Endosc. 2020 Nov;34(11):4916-4923. doi: 10.1007/s00464-019-07280-1. Epub 2019 Dec 2.
6
Two-stage cytoreductive surgery for 'extensive' pseudomyxoma peritonei: A legitimate alternative or salvage strategy?两阶段细胞减灭术治疗“广泛”假性黏液瘤腹膜：合理的替代方案还是挽救策略？
Eur J Surg Oncol. 2024 Oct;50(10):108593. doi: 10.1016/j.ejso.2024.108593. Epub 2024 Aug 8.
7
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.阑尾来源的假性黏液瘤行细胞减灭术（CRS）和腹腔内热灌注化疗（HIPEC）：单中心研究结果。
Updates Surg. 2020 Dec;72(4):1207-1212. doi: 10.1007/s13304-020-00788-5. Epub 2020 May 14.
8
Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China.中国 10 年治疗阑尾黏液性肿瘤腹膜假黏液瘤伴不完全肿瘤细胞减灭术后腹腔热灌注化疗的经验
Orphanet J Rare Dis. 2024 Jan 4;19(1):8. doi: 10.1186/s13023-023-02995-w.
9
Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience.腹腔热灌注化疗治疗假性黏液瘤腹膜转移的疗效分析：10 年经验。
J Gastrointest Surg. 2020 Apr;24(4):899-906. doi: 10.1007/s11605-019-04239-4. Epub 2019 May 14.
10
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.腹腔内热灌注化疗在细胞减灭术后假性黏液瘤中的作用。
JAMA Surg. 2021 Mar 1;156(3):e206363. doi: 10.1001/jamasurg.2020.6363. Epub 2021 Mar 10.

引用本文的文献

1
ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases.ASO 实践指南系列：结直肠腹膜转移的管理
Ann Surg Oncol. 2025 Jun 30. doi: 10.1245/s10434-025-17650-w.

本文引用的文献

1
About the Cover.关于封面。
J Surg Oncol. 2024 Nov;130(6):1160. doi: 10.1002/jso.28054. Epub 2024 Dec 19.
2
ASO Author Reflections: The Paradox of Surgery for Pseudomyxoma Peritonei of Appendiceal Origin-Sometimes the Most Extensive Operations for Histologically Bland Disease.美国外科医师学会作者反思：阑尾源性腹膜假黏液瘤手术的悖论——有时针对组织学表现温和的疾病却需要进行最广泛的手术。
Ann Surg Oncol. 2025 Jan;32(1):249-250. doi: 10.1245/s10434-024-16044-8. Epub 2024 Aug 20.
3
PSOGI-Venice-2023, history in the making.PSOGI - 威尼斯 - 2023，创造历史。
J Surg Oncol. 2024 Nov;130(6):1161-1162. doi: 10.1002/jso.27786. Epub 2024 Jul 31.
4
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial.低级别黏液性阑尾腺癌患者全身化疗的疗效：一项随机交叉试验。
JAMA Netw Open. 2023 Jun 1;6(6):e2316161. doi: 10.1001/jamanetworkopen.2023.16161.
5
The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis.腹膜癌减瘤手术技术熟练之路：风险调整累积求和分析
Front Surg. 2022 May 18;9:877970. doi: 10.3389/fsurg.2022.877970. eCollection 2022.
6
Current Management of Appendiceal Neoplasms.阑尾肿瘤的现行治疗方法。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-15. doi: 10.1200/EDBK_321009.
7
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies.多机构分析细胞减灭术治疗腹膜表面恶性肿瘤患者的教科书结局。
Surg Oncol. 2021 Jun;37:101492. doi: 10.1016/j.suronc.2020.11.006. Epub 2020 Nov 20.
8
Updates in Appendix Pathology: The Precarious Cutting Edge.附录病理学新进展：岌岌可危的前沿领域。
Surg Pathol Clin. 2020 Sep;13(3):469-484. doi: 10.1016/j.path.2020.05.006. Epub 2020 Jul 11.
9
A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology.一项针对胃癌合并癌性腹膜炎或细胞学检查阳性患者的细胞减灭术、胃切除术及腹腔热灌注化疗的II期试验。
Ann Surg Oncol. 2021 Jan;28(1):258-264. doi: 10.1245/s10434-020-08739-5. Epub 2020 Jun 17.
10
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve.细胞减灭术和腹腔内热化疗：技术考虑因素和学习曲线。
J Surg Oncol. 2020 Jul;122(1):85-95. doi: 10.1002/jso.25939. Epub 2020 May 20.